MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma

Clinicopathological Significance of microRNA-31, -143 and -145 Expression in Colorectal Cancer

(2013) Chao-Jie Wang et al.   DISEASE MARKERS

Identification of intergenic trans-regulatory RNAs containing a disease-linked SNP sequence and targeting cell cycle progression/differentiation pathways in multiple common human disorders

(2011) Anna B. Glinskii et al.   CELL CYCLE

Clinical, Pathologic, and Molecular Features of Early-onset Colorectal Carcinoma

(2009) Rhonda K. Yantiss et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Locked Nucleic Acid In situ Hybridization Analysis of miR-21 Expression during Colorectal Cancer Development

(2009) N. Yamamichi et al.   CLINICAL CANCER RESEARCH

MicroRNAs: Novel Biomarkers for Human Cancer

(2009) C. L. Bartels et al.   CLINICAL CHEMISTRY

Plasma microRNAs: a potential biomarker for colorectal cancer?

(2009) A. J Schetter et al.   GUT

Mechanism of growth inhibition by MicroRNA 145: The role of the IGF-I receptor signaling pathway

(2009) Gaspare La Rocca et al.   JOURNAL OF CELLULAR PHYSIOLOGY

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

(2009) Raffaele Baffa et al.   JOURNAL OF PATHOLOGY

The Cdk inhibitor p57Kip2 controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics

(2009) P Vlachos et al.   ONCOGENE

MicroRNAs: A new class of gene regulators

(2008) Douglas J. Guarnieri et al.   ANNALS OF MEDICINE

MicroRNAs: Key players in carcinogenesis and novel therapeutic targets

(2008) A.H.F. Mirnezami et al.   EJSO

MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma

(2008) F Fornari et al.   ONCOGENE